September 15, 2019
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
Read More
September 14, 2019
Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma
Read More
January 30, 2019
A Study of Intrathecal SHP611 in Participants With Late Infantile Metachromatic Leukodystrophy
Read More
January 30, 2019
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Read More
January 30, 2019
A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
Read More
January 30, 2019
A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
Read More
January 30, 2019
Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
Read More
January 30, 2019
Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
Read More
January 30, 2019
Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma
Read More
Load More
X